PWID-3

  • Research type

    Research Study

  • Full title

    Clinical, demographic and social factors influencing recovery after hospitalised infection – assessing the contribution of injection drug use.

  • IRAS ID

    354268

  • Contact name

    Patrick J Lillie

  • Contact email

    p.lillie1@nhs.net

  • Sponsor organisation

    Hull Teaching Hospitals NHS Trust

  • Clinicaltrials.gov Identifier

    SIP1011, PWID-3

  • Duration of Study in the UK

    2 years, 0 months, 0 days

  • Research summary

    Infections in People Who Inject Drugs (PWID) are a significant cause of healthcare utilisation, morbidity and mortality, with recent UK health Security Agency (UKHSA) ‘Shooting up’ reports highlighting their importance. Our recent pilot study highlighted that PWID have impaired health related quality of life (QoL) outcomes, with a significant impact on mental health up to 6 months after hospitalisation with infection, but was while QoL is an important measure, the economic and functional impacts of infection are essential factors influencing patient recovery from infection, which are often overlooked in the acute and longer-term clinical management. Understanding QoL, economic and functional factors in these groups hospitalised with infection can help provide holistic, wrap around care. We would like to see if the impact on QoL and functional outcomes is specific to due to a patients drug use regardless of infection or is it the infection that is determining factor.

  • REC name

    Wales REC 5

  • REC reference

    25/WA/0241

  • Date of REC Opinion

    29 Aug 2025

  • REC opinion

    Favourable Opinion